2.4.1.9 Html 91 197 1 false 28 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.bio-techne.com/20141231/role/statement-document-and-entity-information Document And Entity Information false false R2.htm 001 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) Sheet http://www.bio-techne.com/20141231/role/statement-condensed-consolidated-statements-of-earnings-and-comprehensive-income-unaudited Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) false false R3.htm 002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) (Parentheticals) Sheet http://www.bio-techne.com/20141231/role/statement-condensed-consolidated-statements-of-earnings-and-comprehensive-income-unaudited-parentheticals Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) (Parentheticals) true false R4.htm 003 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.bio-techne.com/20141231/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) false false R5.htm 004 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.bio-techne.com/20141231/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.bio-techne.com/20141231/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) false false R7.htm 006 - Disclosure - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.bio-techne.com/20141231/role/statement-note-1-basis-of-presentation-and-summary-of-significant-accounting-policies Note 1 - Basis of Presentation and Summary of Significant Accounting Policies false false R8.htm 007 - Disclosure - Note 2 - Acquisitions Sheet http://www.bio-techne.com/20141231/role/statement-note-2-acquisitions Note 2 - Acquisitions false false R9.htm 008 - Disclosure - Note 3 - Debt and Other Financing Arrangements Sheet http://www.bio-techne.com/20141231/role/statement-note-3-debt-and-other-financing-arrangements Note 3 - Debt and Other Financing Arrangements false false R10.htm 009 - Disclosure - Note 4 - Segment Information Sheet http://www.bio-techne.com/20141231/role/statement-note-4-segment-information Note 4 - Segment Information false false R11.htm 010 - Disclosure - Note 5 - Share-based Compensation Sheet http://www.bio-techne.com/20141231/role/statement-note-5-sharebased-compensation- Note 5 - Share-based Compensation false false R12.htm 011 - Disclosure - Note 6 - Other Income, Net Sheet http://www.bio-techne.com/20141231/role/statement-note-6-other-income-net Note 6 - Other Income, Net false false R13.htm 012 - Disclosure - Note 7 - Income Taxes Sheet http://www.bio-techne.com/20141231/role/statement-note-7-income-taxes Note 7 - Income Taxes false false R14.htm 013 - Disclosure - Note 8 - Earnings Per Share Sheet http://www.bio-techne.com/20141231/role/statement-note-8-earnings-per-share Note 8 - Earnings Per Share false false R15.htm 014 - Document - Note 9 - Accumulated Other Comprehensive Income Sheet http://www.bio-techne.com/20141231/role/statement-note-9-accumulated-other-comprehensive-income Note 9 - Accumulated Other Comprehensive Income false false R16.htm 015 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.bio-techne.com/20141231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) false false R17.htm 016 - Disclosure - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.bio-techne.com/20141231/role/statement-note-1-basis-of-presentation-and-summary-of-significant-accounting-policies-tables Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Tables) false false R18.htm 017 - Disclosure - Note 2 - Acquisitions (Tables) Sheet http://www.bio-techne.com/20141231/role/statement-note-2-acquisitions-tables Note 2 - Acquisitions (Tables) false false R19.htm 018 - Disclosure - Note 4 - Segment Information (Tables) Sheet http://www.bio-techne.com/20141231/role/statement-note-4-segment-information-tables Note 4 - Segment Information (Tables) false false R20.htm 019 - Disclosure - Note 6 - Other Income, Net (Tables) Sheet http://www.bio-techne.com/20141231/role/statement-note-6-other-income-net-tables Note 6 - Other Income, Net (Tables) false false R21.htm 020 - Disclosure - Note 8 - Earnings Per Share (Tables) Sheet http://www.bio-techne.com/20141231/role/statement-note-8-earnings-per-share-tables Note 8 - Earnings Per Share (Tables) false false R22.htm 021 - Disclosure - Note 9 - Accumulated Other Comprehensive Income (Tables) Sheet http://www.bio-techne.com/20141231/role/statement-note-9-accumulated-other-comprehensive-income-tables Note 9 - Accumulated Other Comprehensive Income (Tables) false false R23.htm 022 - Disclosure - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) Sheet http://www.bio-techne.com/20141231/role/statement-note-1-basis-of-presentation-and-summary-of-significant-accounting-policies-details-textual Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) false false R24.htm 023 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Inventories (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-1-basis-of-presentation-and-summary-of-significant-accounting-policies-inventories-details Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Inventories (Details) false false R25.htm 024 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Property and Equipment (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-1-basis-of-presentation-and-summary-of-significant-accounting-policies-property-and-equipment-details Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Property and Equipment (Details) false false R26.htm 025 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Intangible Assets (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-1-basis-of-presentation-and-summary-of-significant-accounting-policies-intangible-assets-details Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Intangible Assets (Details) false false R27.htm 026 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Changes to Carrying Amount of Net Intangible Assets (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-1-basis-of-presentation-and-summary-of-significant-accounting-policies-changes-to-carrying-amount-of-net-intangible-assets-details Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Changes to Carrying Amount of Net Intangible Assets (Details) false false R28.htm 027 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Estimated Future Amortization Expense for Intangible Assets (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-1-basis-of-presentation-and-summary-of-significant-accounting-policies-estimated-future-amortization-expense-for-intangible-assets-details Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Estimated Future Amortization Expense for Intangible Assets (Details) false false R29.htm 028 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Changes in Carrying Amount of Goodwill (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-1-basis-of-presentation-and-summary-of-significant-accounting-policies-changes-in-carrying-amount-of-goodwill-details Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Changes in Carrying Amount of Goodwill (Details) false false R30.htm 029 - Disclosure - Note 2 - Acquisitions (Details Textual) Sheet http://www.bio-techne.com/20141231/role/statement-note-2-acquisitions-details-textual Note 2 - Acquisitions (Details Textual) false false R31.htm 030 - Statement - Note 2 - Acquisitions - Preliminary Estimated Fair Values of Assets Acquired and Liabilities Assumed Pending Final Valuation of Intangible Assets (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-2-acquisitions-preliminary-estimated-fair-values-of-assets-acquired-and-liabilities-assumed-pending-final-valuation-of-intangible-assets-details Note 2 - Acquisitions - Preliminary Estimated Fair Values of Assets Acquired and Liabilities Assumed Pending Final Valuation of Intangible Assets (Details) false false R32.htm 031 - Statement - Note 2 - Acquisitions - Condensed Consolidated Financial Statements by Acquisition (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-2-acquisitions-condensed-consolidated-financial-statements-by-acquisition-details Note 2 - Acquisitions - Condensed Consolidated Financial Statements by Acquisition (Details) false false R33.htm 032 - Statement - Note 2 - Unaudited Pro Forma Information (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-2-unaudited-pro-forma-information-details Note 2 - Unaudited Pro Forma Information (Details) false false R34.htm 033 - Disclosure - Note 3 - Debt and Other Financing Arrangements (Details Textual) Sheet http://www.bio-techne.com/20141231/role/statement-note-3-debt-and-other-financing-arrangements-details-textual Note 3 - Debt and Other Financing Arrangements (Details Textual) false false R35.htm 034 - Disclosure - Note 4 - Segment Information (Details Textual) Sheet http://www.bio-techne.com/20141231/role/statement-note-4-segment-information-details-textual Note 4 - Segment Information (Details Textual) false false R36.htm 035 - Statement - Note 4 - Segment Information - Financial Information Relating to Reportable Segments (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-4-segment-information-financial-information-relating-to-reportable-segments-details Note 4 - Segment Information - Financial Information Relating to Reportable Segments (Details) false false R37.htm 036 - Disclosure - Note 5 - Share-based Compensation (Details Textual) Sheet http://www.bio-techne.com/20141231/role/statement-note-5-sharebased-compensation-details-textual Note 5 - Share-based Compensation (Details Textual) false false R38.htm 037 - Statement - Note 6 - Other (Expense) / Income - Schedule of Components of Other (Expense) Income (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-6-other-expense-income-schedule-of-components-of-other-expense-income-details Note 6 - Other (Expense) / Income - Schedule of Components of Other (Expense) Income (Details) false false R39.htm 038 - Disclosure - Note 7 - Income Taxes (Details Textual) Sheet http://www.bio-techne.com/20141231/role/statement-note-7-income-taxes-details-textual Note 7 - Income Taxes (Details Textual) false false R40.htm 039 - Disclosure - Note 8 - Earnings Per Share (Details Textual) Sheet http://www.bio-techne.com/20141231/role/statement-note-8-earnings-per-share-details-textual Note 8 - Earnings Per Share (Details Textual) false false R41.htm 040 - Statement - Note 8 - Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-8-earnings-per-share-shares-used-in-the-earnings-per-share-computations-details Note 8 - Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) false false R42.htm 041 - Statement - Note 9 - Accumulated Other Comprehensive Income - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details) Sheet http://www.bio-techne.com/20141231/role/statement-note-9-accumulated-other-comprehensive-income-changes-in-accumulated-other-comprehensive-income-loss-net-of-tax-details Note 9 - Accumulated Other Comprehensive Income - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details) false false All Reports Book All Reports Element us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability had a mix of decimals attribute values: -5 0. Element us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain had a mix of decimals attribute values: -5 0. Element us-gaap_Goodwill had a mix of decimals attribute values: -3 0. Element us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures had a mix of decimals attribute values: -5 0. Element us-gaap_OtherComprehensiveIncomeLossNetOfTax had a mix of decimals attribute values: -3 0. Element us-gaap_SellingGeneralAndAdministrativeExpense had a mix of decimals attribute values: -3 0. Columns in Cash Flows statement 'Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)' have maximum duration 183 days and at least 31 values. Shorter duration columns must have at least one fourth (7) as many values. Column '10/1/2013 - 12/31/2013' is shorter (91 days) and has only 4 values, so it is being removed. Columns in Cash Flows statement 'Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)' have maximum duration 183 days and at least 31 values. Shorter duration columns must have at least one fourth (7) as many values. Column '10/1/2014 - 12/31/2014' is shorter (91 days) and has only 4 values, so it is being removed. 'Monetary' elements on report '023 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Inventories (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '024 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Property and Equipment (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '026 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Changes to Carrying Amount of Net Intangible Assets (Details)' had a mix of different decimal attribute values. Process Flow-Through: 001 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) Process Flow-Through: 002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) (Parentheticals) Process Flow-Through: 003 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Process Flow-Through: Removing column 'Dec. 31, 2013' Process Flow-Through: Removing column 'Jun. 30, 2013' Process Flow-Through: 004 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Process Flow-Through: 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Process Flow-Through: 023 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Inventories (Details) Process Flow-Through: 024 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Property and Equipment (Details) Process Flow-Through: 025 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Intangible Assets (Details) Process Flow-Through: 026 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Changes to Carrying Amount of Net Intangible Assets (Details) Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '6 Months Ended Dec. 31, 2013' Process Flow-Through: 027 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Estimated Future Amortization Expense for Intangible Assets (Details) Process Flow-Through: Removing column 'Jun. 30, 2014' Process Flow-Through: 028 - Statement - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Changes in Carrying Amount of Goodwill (Details) Process Flow-Through: 030 - Statement - Note 2 - Acquisitions - Preliminary Estimated Fair Values of Assets Acquired and Liabilities Assumed Pending Final Valuation of Intangible Assets (Details) Process Flow-Through: Removing column '6 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column 'Jun. 30, 2014' Process Flow-Through: Removing column 'Nov. 03, 2014' Process Flow-Through: 031 - Statement - Note 2 - Acquisitions - Condensed Consolidated Financial Statements by Acquisition (Details) Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '6 Months Ended Dec. 31, 2013' Process Flow-Through: 032 - Statement - Note 2 - Unaudited Pro Forma Information (Details) Process Flow-Through: 035 - Statement - Note 4 - Segment Information - Financial Information Relating to Reportable Segments (Details) Process Flow-Through: 037 - Statement - Note 6 - Other (Expense) / Income - Schedule of Components of Other (Expense) Income (Details) Process Flow-Through: 040 - Statement - Note 8 - Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) Process Flow-Through: 041 - Statement - Note 9 - Accumulated Other Comprehensive Income - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details) Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '6 Months Ended Dec. 31, 2013' tech-20141231.xml tech-20141231.xsd tech-20141231_cal.xml tech-20141231_def.xml tech-20141231_lab.xml tech-20141231_pre.xml true true